English | Español

SHARE integrates with Highlands Oncology Group in Northwest Arkansas to send Population-Based Cancer Surveillance to the Arkansas Central Cancer Registry (ACCR)

Mon, 06/17/2019 - 08:00 -- Whitney Mayo

 

Little Rock, Arkansas – June, 2019   SHARE is connected to Highlands Oncology Group (HOG) in Northwest Arkansas.  With 4 locations, their doctors have been providing excellence in cancer care in Northwest Arkansas for decades. Their comprehensive program enables patients to see multiple specialists and support services all under one roof at their convenient locations in Rogers and Fayetteville, Arkansas. They serve the entire Northwest Arkansas, South West Missouri, South East Oklahoma regions.

They are setting the bar for cancer treatment in their region and see patients from Bentonville, Rogers, Springdale, Fayetteville, Siloam Springs, Bella Vista, and all surrounding communities. Highlands Oncology Group provides chemotherapy, radiation therapy, diagnostic imaging, pharmacy, counseling, C.A.R.E. clinic (cancer assessment and risk education), infusion center, physical therapy, cancer treatment and surgeries.

Population-based cancer surveillance is critical in North America for cancer control activities aimed at reducing the morbidity and mortality of cancer, the second leading cause of death in the United States. The Arkansas Central Cancer Registry (ACCR) is a population-based registry designed to collect timely and complete data on all cancer cases diagnosed in the state. Highlands Oncology Group locations are implementing their cancer data to go through the SHARE cancer registry interface to the Arkansas Department of Health (ADH) Cancer Registry. By having this connection, SHARE is assisting the clinics in meeting the Promoting Interoperability Program (formally Meaningful Use) requirements as well as Merit-based Incentive Payment System (MIPS).

The Highlands Oncology Group clinics locations are live with sharing data through an interface with their Flatiron EMR system. This allows their referral providers to quickly access patient health data such as; conditions, diagnosis, medical history, social determinants of health (SDOH), medications, vitals and allergies in a secure and efficient manner.

The care coordinators at clinic locations are accessing SHAREs’ Virtual Health Record that aggregates patients record outside of their system of local EMR system and enables a more accurate diagnoses, faster and more effective treatment, and better outcomes for the patient.

Cancer is the second leading cause of death behind heart disease in Arkansas. The most frequently diagnosed cancers in the state include lung, colorectal, breast cancer among women, and prostate cancer among men. It is important for SHARE to connect to the Arkansas Central Cancer Registry so that the Arkansas Department of Health can collect cancer information. This information can be used for surveillance to conduct cancer investigations, to assist initiatives for early detection and prevention, and to supply data for research and policy endeavors.

Highlands Oncology Group’s four clinical sites employ 400 staff members who collectively see nearly 6,000 patients each year. Among the staff are 11 medical oncologists, three radiation oncologists, two supportive care physicians, two surgeons, four social workers, two physical therapists, two massage therapists, 52 registered nurses, and one genetic counselor—all directly employed by Highlands. Four oncology pharmacists work in two specialty pharmacies, and a third pharmacy is opening in 2020.

The two largest sites—a 50,000-foot facility in Rogers, Arkansas, and a 20,000-foot facility in Fayetteville, Arkansas—offer multidisciplinary services for all major cancer types. Highlands also has a separate facility for surgical oncology—gynecological and colorectal—in addition to a building for the lung cancer screening program and the Center for Chest Care. Highlands Oncology Group- Springdale is planned on being opened in 2020.

About Highlands Oncology Group:

Their doctors have been providing excellence in cancer care in Northwest Arkansas for decades. Their comprehensive program enables patients to see multiple specialists and support services all under one roof at their convenient locations in Rogers, Arkansas or Fayetteville, Arkansas. They serve the entire Northwest Arkansas, SW Missouri, SE Oklahoma regions. They are proud to set the bar for cancer treatment in their region and see patients from Bentonville, Rogers, Springdale, Fayetteville, Siloam Springs, Bella Vista, and all surrounding communities.

Certifications

American College of Radiology: ACR accreditation is recognized as the gold standard in medical imaging. Since 1987, the ACR has accredited more than 38,000 facilities in 10 imaging modalities. ACR accreditation helps assure patients that this facility provides the highest level of image quality and safety.

Clinical Laboratory Improvement Amendments: The Centers for Medicare & Medicaid Services (CMS) regulates all laboratory testing (except research) performed on humans in the U.S. through the Clinical Laboratory Improvement Amendments (CLIA). In total, CLIA covers approximately 251,000 laboratory entities. The Division of Laboratory Services, within the Survey and Certification Group, under the Center for Clinical Standards and Quality (CCSQ) has the responsibility for implementing the CLIA Program. The objective of the CLIA program is to ensure quality laboratory testing. Although all clinical laboratories must be properly certified to receive Medicare or Medicaid payments, CLIA has no direct Medicare or Medicaid program responsibilities.

Lung Cancer Alliance Screening Center of Excellence: The National Framework for Lung Cancer Screening Excellence and Continuum of Care is a program administered by the Lung Cancer Alliance. For more information about the Lung Cancer Alliance, visit their website at lungcanceralliance.org.

Klose Training Lypmhedema Certification: A lymphedema certification course that trains therapists to safely and effectively treat patients with lymphatic disorders. Complete Decongestive Therapy (CDT) is the standard of care for the treatment of primary and secondary lymphedema.

Oncology Certified Nurses Certification: OCN certification is a validation of a nurse’s knowledge in adult oncology. Highlands Oncology Group has several nurses with this certification.

Da Vinci Surgical System: Dr. Joseph J. Ivy, board certified OB/GYN, is a nationally recognized expert in minimally invasive gynecologic cancer surgery using the Da Vinci surgical system. He is a certified surgeon lead trainer for robotic surgery and has the state’s largest clinical experience with robotic gynecologic oncology procedures.

For more information visit: https://highlandsoncologygroup.com